Welcome to ConnecticutLifeScience.com
ConnecticutLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Connecticut
Are you considering a move to Connecticut? Relocating your business to
Connecticut? Starting a company? Or just interested in Connecticut?
This section will answer many of your questions regarding the life science industry in Connecticut, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- AstraZeneca granted temporary restraining order in PULMICORT RESPULES patent litigation On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation suspension product, a generic version of AstraZeneca's PULMICORT RESPULES treatment.
AstraZeneca November 20, 2008
- AstraZeneca to realign supply chain to improve productivity and move closer to customers AstraZeneca has announced proposed changes to its global manufacturing and supply chain operations as part of its ongoing programme to improve efficiency across the business.
AstraZeneca November 20, 2008
- FDA Advisory Committee provides opinion on oritavancin Targanta Therapeutics announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive pathogens, received a mixed review from the FDA's Anti-Infective Drugs Advisory Committee.
Targanta Therapeutics Corporation November 19, 2008
- Amgen, Takeda and Millennium provide update on Phase 3 trial of motesanib Amgen and Millennium announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended.
Amgen November 19, 2008
- Pharmos announces results from Phase 2a of topical Diclofenac NanoEmulsion cream Pharmos announced results from its Phase 2a clinical trial of its topical NanoEmulsion (NE) drug delivery technology formulated with 3% Diclofenac Diethanolamine. The study did not achieve statistical significance in its primary efficacy endpoint, nor in several secondary endpoints.
Pharmos Corporation November 19, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Connecticut's BioHistory
Why is there a biotechnology industry in Connecticut? Will the industry continue
to grow in Connecticut? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Connecticut BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Connecticut.
More...
BioEvolution Posters
More...
November is American Diabetes Month
Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart
disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million)
of them don't know that they have the disease. Millions more are at risk of developing diabetes.
Diabetes is a costly disease associated with serious complications and premature death. It is a major
cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury,
kidney failure, and new blindness in adults.
More...
BioFact
(1981) - The U.S. General Accounting Office releases a scathing report on the National Plant Germplasm System, saying that it lacks a sense of direction and purpose and does not have effective, centralized management.
It's a Small World
|
| |
Plant Cells
| |
Science Quote
"Chance favors the prepared mind."
| - |
Louis Pasteur, French microbiologist and chemist
|
|
(1822-1895)
|
|
